CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
RecruitingNCT06700304Phase: NAStarted 2024-11-20
Summary
The CAN-PRIME Study is to test the safety and functionality of Neuralink's N1 Implant and R1 Robot in people who have difficulty moving their arms and legs (tetraparesis or tetraplegia). The N1 Implan
Eligibility
Sex
ALL
Min Age
19 Years
Max Age
None
Locations
University Health NetworkToronto, Ontario, Canada
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06700304